ARCHIVES

BRCA 1 Mutation Finding Draws Attention To Potential Perils Of Genetic Testing

This article is from The Cancer Letter archive.

Vol. 21 No. 38 | October 6, 1995

Download PDF Visit The Full Archive

Related Articles

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

Annual Report Key Element In Prevention Drive, Maquire Insists

February 2, 1979

New Research Grant Awards

October 18, 1974

Two founding cancer center directors step down: Harold Moses at Vanderbilt-Ingram and Charles Coltman at CTRC.

November 19, 2004

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

November 7, 2008

NCAB Approves Characteristics for Recognition As Comprehensive; Outlook Dim for New Division

May 19, 1989